U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Resources for You (Biologics)
  4. Healthcare Providers (Biologics)
  1. Resources for You (Biologics)

Healthcare Providers (Biologics)

Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. The Center for Biologics Evaluation and Research (CBER) is responsible for ensuring the safety and efficacy of the biological products.

An Investigational New Drug Application (IND) is a request for authorization from the Food and Drug Administration (FDA) to administer an investigational drug or biological product to humans. Such authorization must be secured prior to interstate shipment and administration of any new drug or biological product that is not the subject of an approved New Drug Application or Biologics/Product License Application. In rare instances a physician may request an Emergency Use IND for a patient. Contact information for Emergency Use IND Requests:

  • For investigational biological products regulated by CBER, call 240-402-7800
  • For all other investigational drugs, call 301-796-3400 or 1-855-543-3784
  • After working hours, call FDA's Office of Emergency Operations at 301-796-8240

Blood & Blood Products

Tissue & Tissue Products

Vaccines

Xenotransplantation

Guidance, Compliance & Regulatory Information

Safety & Availability

Cell and Gene Therapy Products

Resources for You
Recalls & Alerts
Approvals & Clearances
More Information

Sub-Topic Paragraphs

Paragraph Header
Follow CBER


Subscribe for CBER Updates

Get e-mail updates on What’s New at CBER!